LAV Summit Ltd 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 12:26 pm Sale |
2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
LAV Summit Ltd | 151,992 0.400% |
-2,321,439 (-93.86%) |
Filing |
| 2021-02-09 4:46 pm Purchase |
2020-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
LAV Summit Ltd | 2,473,431 6.600% |
2,473,431 (New Position) |
Filing |